About
ViroCarb develops broad-spectrum antiviral therapies aimed at treating and preventing multiple viral infections including COVID-19, HIV, Herpes, and Coronavirus.
Explore ViroCarb's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.